Scope of Disclosure
Conflicts of interest that authors are obligated to disclose are limited to matters in connection with companies or for-profit organizations connected with the submission content.
At the Time of Manuscript Submission
Authors of the society’s official journal the Journal of Hepato-Biliary-Pancreatic Sciences or other publications must clearly indicate at the time of submission any conflicts of interest by means of Author Disclosure of Relevant Financial Relationships, which is prescribed in the Instructions to Authors. Conflicts of interest should be stated at the end of a research paper immediately before the references. If no conflict exists, authors should state “The authors declare that they have no conflict of interest.” With regard to conflicts of interest to be clearly indicated at the time of submission, authors shall disclose matters prescribed below. Matters for which disclosure is required shall be matters that occur from three years before paper submission to the time of submission.
Authors should refer to Article 1 of the Detailed Implementation Rules for Guidelines on Conflicts of Interest in Surgery Research of the Japanese Society for Hepato-biliary-Pancreatic Surgery below for further guidance on how much detail to include in the conflict of interest statement.
- Authors who are officers or advisors of companies or for-profit organizations shall report remuneration from a single company or organization that exceeds 1,000,000 yen (equivalent) per year.
- Authors shall report stock ownership in cases where profit (the sum of dividends and profit on sale) from shares of a single company during a twelve-month period exceeds 1,000,000 yen (equivalent), or where they own over 5% of the relevant total shares.
- Authors shall report patent royalties or licensing fees from companies or for-profit organizations in cases where royalties or licensing fees for a single patent exceed 1,000,000 yen (equivalent) per year.
- Authors shall report compensation (such as lecture fees) paid by companies or for-profit organizations for the time or labor of a researcher engaged for conference attendance (or presentation) in cases where such compensation from a single company or organization exceeds 1,000,000 yen (equivalent) per year.
- Authors s shall report manuscript fees paid by companies or for-profit organizations as compensation for writing a pamphlet or other publication in cases where manuscript fees from a single company or organization exceed 1,000,000 yen (equivalent) per year.
- Authors shall report research funding from companies or for-profit organizations in cases where the reporting party is actually allocated funds in excess of 1,000,000 yen (equivalent) by a single company or organization for medical research (e.g. consigned research funds, joint research funds, clinical trial funds), and if the use of the funding is substantively determined by the reporting party.
- Authors shall report grants (donations) from companies or organizations in cases where the reporting party individually or the reporting party’s department (chair, field) or a representative of their laboratory is actually allocated a donation in excess of 1,000,000 yen (equivalent) by a single company or organization, and if the use of the funding is substantively determined by the reporting party.
- Authors shall report cases in which they have accepted researchers or other personnel from companies or for-profit organizations.
- Authors shall report cases in which they hold a chair (or belong to a sponsored course) funded by companies or for-profit organizations.
- Authors shall report other remuneration (travel, gifts, or other in-kind payments not directly related to research) in cases where such remuneration received from a single company or organization exceeds 50,000 yen (equivalent) per year.
